These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37063966)

  • 21. Gata6
    Deniset JF; Belke D; Lee WY; Jorch SK; Deppermann C; Hassanabad AF; Turnbull JD; Teng G; Rozich I; Hudspeth K; Kanno Y; Brooks SR; Hadjantonakis AK; O'Shea JJ; Weber GF; Fedak PWM; Kubes P
    Immunity; 2019 Jul; 51(1):131-140.e5. PubMed ID: 31315031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of EP4 receptor limits transition of acute to chronic heart failure in lipoxygenase deficient mice.
    Kain V; Ingle KA; Rajasekaran NS; Halade GV
    Theranostics; 2021; 11(6):2742-2754. PubMed ID: 33456570
    [No Abstract]   [Full Text] [Related]  

  • 23. Nanoparticle-Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial Infarction.
    Kwon SP; Hwang BH; Park EH; Kim HY; Lee JR; Kang M; Song SY; Jung M; Sohn HS; Kim E; Kim CW; Lee KY; Oh GC; Choo E; Lim S; Chung Y; Chang K; Kim BS
    Small; 2021 Aug; 17(32):e2101207. PubMed ID: 34216428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation in cardiac injury, repair and regeneration.
    Frangogiannis NG
    Curr Opin Cardiol; 2015 May; 30(3):240-5. PubMed ID: 25807226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple roles of cardiac macrophages in heart homeostasis and failure.
    Moskalik A; Niderla-Bielińska J; Ratajska A
    Heart Fail Rev; 2022 Jul; 27(4):1413-1430. PubMed ID: 34387811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.
    Tripathi H; Al-Darraji A; Abo-Aly M; Peng H; Shokri E; Chelvarajan L; R Donahue R; Levitan BM; Gao E; Hernandez G; Morris AJ; Smyth SS; Abdel-Latif A
    J Mol Cell Cardiol; 2020 Dec; 149():95-114. PubMed ID: 33017574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis.
    Hu S; Yang M; Huang S; Zhong S; Zhang Q; Ding H; Xiong X; Hu Z; Yang Y
    Front Cardiovasc Med; 2022; 9():818188. PubMed ID: 35330948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDAC inhibition helps post-MI healing by modulating macrophage polarization.
    Kimbrough D; Wang SH; Wright LH; Mani SK; Kasiganesan H; LaRue AC; Cheng Q; Nadig SN; Atkinson C; Menick DR
    J Mol Cell Cardiol; 2018 Jun; 119():51-63. PubMed ID: 29680681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target.
    Schimmel K; Ichimura K; Reddy S; Haddad F; Spiekerkoetter E
    Front Cardiovasc Med; 2022; 9():886553. PubMed ID: 35600469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid-Epithelial-Reproductive Receptor Tyrosine Kinase and Milk Fat Globule Epidermal Growth Factor 8 Coordinately Improve Remodeling After Myocardial Infarction via Local Delivery of Vascular Endothelial Growth Factor.
    Howangyin KY; Zlatanova I; Pinto C; Ngkelo A; Cochain C; Rouanet M; Vilar J; Lemitre M; Stockmann C; Fleischmann BK; Mallat Z; Silvestre JS
    Circulation; 2016 Mar; 133(9):826-39. PubMed ID: 26819373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topiramate modulates post-infarction inflammation primarily by targeting monocytes or macrophages.
    Wang Z; Huang S; Sheng Y; Peng X; Liu H; Jin N; Cai J; Shu Y; Li T; Li P; Fan C; Hu X; Zhang W; Long R; You Y; Huang C; Song Y; Xiang C; Wang J; Yang Y; Liu K
    Cardiovasc Res; 2017 Apr; 113(5):475-487. PubMed ID: 28339742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: consensus document from the joint 2019 meeting of the ESC Working Groups of cellular biology of the heart and myocardial function.
    Steffens S; Van Linthout S; Sluijter JPG; Tocchetti CG; Thum T; Madonna R
    Cardiovasc Res; 2020 Sep; 116(11):1850-1862. PubMed ID: 32396608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immune system and cardiac repair.
    Frangogiannis NG
    Pharmacol Res; 2008 Aug; 58(2):88-111. PubMed ID: 18620057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetics of Aberrant Cardiac Wound Healing.
    Russell-Hallinan A; Watson CJ; Baugh JA
    Compr Physiol; 2018 Mar; 8(2):451-491. PubMed ID: 29687888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac CD68+ and stabilin-1+ macrophages in wound healing following myocardial infarction: From experiment to clinic.
    Ryabov V; Gombozhapova A; Rogovskaya Y; Kzhyshkowska J; Rebenkova M; Karpov R
    Immunobiology; 2018; 223(4-5):413-421. PubMed ID: 29179985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Characteristic of Resident Macrophages and their Therapeutic Potential for Myocardial Infarction.
    Wang J; Li J; Yang Z; Chen Y; Shen H; Chen L; Chen Y; Shen Z
    Curr Probl Cardiol; 2023 May; 48(5):101570. PubMed ID: 36584729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KLF9 deficiency protects the heart from inflammatory injury triggered by myocardial infarction.
    Chang Z; Li H
    Korean J Physiol Pharmacol; 2023 Mar; 27(2):177-185. PubMed ID: 36815257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
    Frangogiannis NG
    Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
    Shirakawa K; Endo J; Kataoka M; Katsumata Y; Yoshida N; Yamamoto T; Isobe S; Moriyama H; Goto S; Kitakata H; Hiraide T; Fukuda K; Sano M
    Circulation; 2018 Oct; 138(18):2021-2035. PubMed ID: 29967195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.
    Tokutome M; Matoba T; Nakano Y; Okahara A; Fujiwara M; Koga JI; Nakano K; Tsutsui H; Egashira K
    Cardiovasc Res; 2019 Feb; 115(2):419-431. PubMed ID: 30084995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.